Breast Cancer

Alliance to study use of magnetic resonance focused ultrasound to eliminate breast tumors

Published in Women's Health Weekly, December 29th, 2005

InSightec, Ltd. is partnering with the American College of Radiology Imaging Network (ACRIN) to enroll patients in a phase II study assessing how effectively the ExAblate 2000 technology can ablate, or destroy, cancerous breast tumors.

If effective, this outpatient procedure could become a potential non-invasive treatment alternative to lumpectomies or surgical removal of breast tumors and the surrounding area of normal tissue.

The ExAblate 2000 combines magnetic resonance imaging (MRI) with highly-focused ultrasound to non-invasively thermally ablate (destroy) tumors in the body. Currently, the technology is used to treat uterine fibroids, a benign...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2005-12-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry